Alefacept in combination with methotrexate for treatment of active psoriatic arthritis: Rationale and design of a randomized, double-blind, placebo-controlled study

被引:0
|
作者
Gladman, D
Keystone, E
Gottlieb, A
机构
[1] Toronto Hosp, Western Div, Ctr Prognosis Studies, Toronto, ON M5T 2S8, Canada
[2] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
关键词
D O I
10.1016/j.jaad.2003.10.229
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P227
引用
收藏
页码:P60 / P60
页数:1
相关论文
共 50 条
  • [1] Alefacept in combination with methotrexate for the treatment of psoriatic arthritis - Results of a randomized, double-blind, placebo-controlled study
    Mease, Philip J.
    Gladman, Dafna D.
    Keystone, Edward C.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1638 - 1645
  • [2] Alefacept with methotrexate for treatment of psoriatic arthritis: Open-label extension of a randomized, double-blind, placebo-controlled study
    Mease, Philip J.
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : 402 - 411
  • [3] on behalf of the Alefacept in Psoriatic Arthritis Study Group. Alefacept with methotrexate for treatment of psoriatic arthritis: open-label extension of a randomized, double-blind, placebo-controlled study (vol 60, pg 402, 2009)
    Libow, L. F.
    Forman, S. B.
    Ferringer, T. C.
    Peckham, S. J.
    Dalton, S. R.
    Sasaki, G. T.
    Elston, D. M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (03) : 507 - 507
  • [4] Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study
    Schett, Georg
    Wollenhaupt, Jurgen
    Papp, Kim
    Joos, Rik
    Rodrigues, Jude F.
    Vessey, Adele R.
    Hu, ChiaChi
    Stevens, Randall
    de Vlam, Kurt L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : 3156 - 3167
  • [5] Chikungunya Arthritis Treatment with Methotrexate and Dexamethasone: A Randomized, Double-blind, Placebo-controlled Trial
    Amaral, Jose Kennedy
    Lucena, Gabriela
    Schoen, Robert Taylor
    CURRENT RHEUMATOLOGY REVIEWS, 2024, 20 (03) : 337 - 346
  • [6] Alefacept for Severe Alopecia Areata A Randomized, Double-blind, Placebo-Controlled Study
    Strober, Bruce E.
    Menon, Kavita
    McMichael, Amy
    Hordinsky, Maria
    Krueger, Gerald
    Panko, Jackie
    Siu, Kimberly
    Lustgarten, Jonathan L.
    Ross, Elizabeth K.
    Shapiro, Jerry
    ARCHIVES OF DERMATOLOGY, 2009, 145 (11) : 1262 - 1266
  • [7] Vunakizumab in Patients with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study
    Zou, Hejian
    Wan, Weiguo
    Xue, Yu
    Sun, Lingyun
    Zhang, Ning
    Chen, Haiying
    Shi, Xiaofei
    Liu, Shengyun
    Chen, Lin
    Ma, Xinmei
    Wei, Hua
    Jiang, Zhenyu
    Li, Xiaomei
    Fan, Hongtao
    Li, Hongbin
    Li, Jingyang
    Wu, Rui
    Shi, Guixiu
    Zhu, Jing
    Kong, Xiaodan
    Lu, Yuewu
    Cui, Xiaojing
    Zheng, Qianning
    Bai, Xiaoyan
    Dong, Guangchao
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5240 - 5242
  • [8] SULFASALAZINE IN PSORIATIC-ARTHRITIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    FARR, M
    KITAS, GD
    WATERHOUSE, L
    JUBB, R
    FELIXDAVIES, D
    BACON, PA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1990, 29 (01): : 46 - 49
  • [9] Cannabidiol Treatment in Hand Osteoarthritis and Psoriatic Arthritis - A Randomized, Double-blind Placebo-controlled Trial
    Vela, Jonathan
    Kristensen, Salome
    Dreyer, Lene
    Petersen, Kristian Kjaer
    Nielsen, Lars Arendt
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3056 - 3057
  • [10] Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
    Vela, Jonathan
    Dreyer, Lene
    Petersen, Kristian Kjaer
    Arendt-Nielsen, Lars
    Duch, Kirsten Skjaerbaek
    Kristensen, Salome
    PAIN, 2022, 163 (06) : 1206 - 1214